Relay Therapeutics Overview
Relay Therapeutics Target Price
Analysts' 12-month price predictions for RLAY.
Get informed when a big investor buys or sells
+ FollowShare Price
$18.65
Average Target Price
$23.89
28.1% upside
28.1% upside9 analysts in the last 4 months
High: $28 | Low: $18
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-26 | GuggenheimBrad Canino | $26 | 39.4% upside |  |
| 2026-05-26 | H.C. Wainwright | $28 | 50.1% upside | |
| 2026-05-20 | Barclays | $27 | 44.8% upside | |
| 2026-05-19 | UBS | $26 | 39.4% upside | |
| 2026-04-29 | H.C. Wainwright | $25 | 34% upside | |
| 2026-04-28 | Oppenheimer | $18 |  3.5% downside | |
| 2026-04-28 | Wells Fargo | $21 | 12.6% upside | |
| 2026-04-28 | Goldman SachsSalveen Richter | $22 | 18% upside | |
| 2026-03-13 | GuggenheimBrad Canino | $22 | 18% upside | |
| 2026-01-26 | Oppenheimer | $14 | 24.9% downside | |
| 2025-12-12 | Wells Fargo | $13 | 30.3% downside | |
| 2024-09-16 | H.C. WainwrightRobert Burns | $19 | 1.9% upside | |
| 2024-09-10 | JefferiesAkash Tewari | $16 | 14.2% downside | |
| 2024-09-09 | BarclaysPeter Lawson | $17 | 8.8% downside | |
| 2024-09-04 | Bank of America SecuritiesJason Gerberry | $20 | 7.2% upside | |
| 2024-05-10 | BarclaysPeter Lawson | $15 | 19.6% downside | |
| 2024-05-06 | OppenheimerMatt Biegler | $25 | 34% upside | |
| 2023-04-20 | JefferiesAkash Tewari | $12.5 | 33% downside | |
| 2023-02-03 | Oppenheimer | $33 | 76.9% upside | |
| 2022-09-30 | BarclaysPeter Lawson | $23 | 23.3% upside | |